BCAX (BCAX) Form 144 shows option exercises and Ryan Cohlhepp sales
Rhea-AI Filing Summary
BCAX files Form 144 reporting proposed sales of Common stock and recent dispositions by a holder. The filing lists securities to be sold from option exercises including 05/12/2024 (4,500 shares) and 03/16/2026 (8,000 shares). It also reports actual Common stock sales by Ryan Cohlhepp on 01/15/2026 (149 shares, $2,684.98), 01/22/2026 (3,828 shares, $69,295.99), 02/25/2026 (3,631 shares, $69,132.42), and 03/03/2026 (17,392 shares, $315,892.64).
Positive
- None.
Negative
- None.
Insights
Form 144 lists proposed resale of shares from option exercises and several completed sales by a named holder.
The filing records two option-exercise related sale entries: 05/12/2024 for 4,500 shares and 03/16/2026 for 8,000 shares. These are described as "Exercise of Stock Option" with cash consideration.
Separately, the excerpt lists four completed sales by Ryan Cohlhepp with exact share counts and proceeds. The filing provides transaction dates and gross proceeds amounts; it does not state any qualifying conditions or counsel opinion within the provided excerpt.
FAQ
What does BCAX's Form 144 disclose about proposed sales?
Who reported recent sales in the BCAX filing and how many shares were sold?
What proceeds are shown for the largest reported sale in the BCAX excerpt?
Are the proposed sales described as issuer or holder transactions in BCAX's filing?